Cargando…

HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD

Primary Epstein-Barr virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations in solid organ and hematopoietic stem cell transplant recipients are associated with posttransplantation lymphoproliferative disorders (PTLDs). It is still unclear why only a minority of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vietzen, Hannes, Furlano, Philippe L., Cornelissen, Jan J., Böhmig, Georg A., Jaksch, Peter, Puchhammer-Stöckl, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651774/
https://www.ncbi.nlm.nih.gov/pubmed/36477802
http://dx.doi.org/10.1182/blood.2022017650
_version_ 1785136066287632384
author Vietzen, Hannes
Furlano, Philippe L.
Cornelissen, Jan J.
Böhmig, Georg A.
Jaksch, Peter
Puchhammer-Stöckl, Elisabeth
author_facet Vietzen, Hannes
Furlano, Philippe L.
Cornelissen, Jan J.
Böhmig, Georg A.
Jaksch, Peter
Puchhammer-Stöckl, Elisabeth
author_sort Vietzen, Hannes
collection PubMed
description Primary Epstein-Barr virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations in solid organ and hematopoietic stem cell transplant recipients are associated with posttransplantation lymphoproliferative disorders (PTLDs). It is still unclear why only a minority of primary EBV-infected individuals develop IM, and why only some patients progress to EBV(+)PTLD after transplantation. We now investigated whether nonclassic human leukocyte antigen E (HLA-E)–restricted immune responses have a significant impact on the development of EBV diseases in the individual host. On the basis of a large study cohort of 1404 patients and controls as well as on functional natural killer (NK) and CD8(+) T-cell analyses, we could demonstrate that the highly expressed HLA-E∗0103/0103 genotype is protective against IM, due to the induction of potent EBV BZLF1-specific HLA-E–restricted CD8(+) T-cell responses, which efficiently prevent the in vitro viral dissemination. Furthermore, we provide evidence that the risk of symptomatic EBV reactivations in immunocompetent individuals as well as in immunocompromised transplant recipients depends on variations in the inhibitory NKG2A/LMP-1/HLA-E axis. We show that EBV strains encoding for the specific LMP-1 peptide variants GGDPHLPTL or GGDPPLPTL, presented by HLA-E, elicit strong inhibitory NKG2A(+) NK and CD8(+) T-cell responses. The presence of EBV strains encoding for both peptides was highly associated with symptomatic EBV reactivations. The further progression to EBV(+)PTLD was highly associated with the presence of both peptide-encoding EBV strains and the expression of HLA-E∗0103/0103 in the host. Thus, HLA-E–restricted immune responses and the NKG2A/LMP-1/HLA-E axis are novel predictive markers for EBV(+)PTLD in transplant recipients and should be considered for future EBV vaccine design.
format Online
Article
Text
id pubmed-10651774
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-106517742022-12-09 HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD Vietzen, Hannes Furlano, Philippe L. Cornelissen, Jan J. Böhmig, Georg A. Jaksch, Peter Puchhammer-Stöckl, Elisabeth Blood Immunobiology and Immunotherapy Primary Epstein-Barr virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations in solid organ and hematopoietic stem cell transplant recipients are associated with posttransplantation lymphoproliferative disorders (PTLDs). It is still unclear why only a minority of primary EBV-infected individuals develop IM, and why only some patients progress to EBV(+)PTLD after transplantation. We now investigated whether nonclassic human leukocyte antigen E (HLA-E)–restricted immune responses have a significant impact on the development of EBV diseases in the individual host. On the basis of a large study cohort of 1404 patients and controls as well as on functional natural killer (NK) and CD8(+) T-cell analyses, we could demonstrate that the highly expressed HLA-E∗0103/0103 genotype is protective against IM, due to the induction of potent EBV BZLF1-specific HLA-E–restricted CD8(+) T-cell responses, which efficiently prevent the in vitro viral dissemination. Furthermore, we provide evidence that the risk of symptomatic EBV reactivations in immunocompetent individuals as well as in immunocompromised transplant recipients depends on variations in the inhibitory NKG2A/LMP-1/HLA-E axis. We show that EBV strains encoding for the specific LMP-1 peptide variants GGDPHLPTL or GGDPPLPTL, presented by HLA-E, elicit strong inhibitory NKG2A(+) NK and CD8(+) T-cell responses. The presence of EBV strains encoding for both peptides was highly associated with symptomatic EBV reactivations. The further progression to EBV(+)PTLD was highly associated with the presence of both peptide-encoding EBV strains and the expression of HLA-E∗0103/0103 in the host. Thus, HLA-E–restricted immune responses and the NKG2A/LMP-1/HLA-E axis are novel predictive markers for EBV(+)PTLD in transplant recipients and should be considered for future EBV vaccine design. The American Society of Hematology 2023-03-30 2022-12-09 /pmc/articles/PMC10651774/ /pubmed/36477802 http://dx.doi.org/10.1182/blood.2022017650 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Immunobiology and Immunotherapy
Vietzen, Hannes
Furlano, Philippe L.
Cornelissen, Jan J.
Böhmig, Georg A.
Jaksch, Peter
Puchhammer-Stöckl, Elisabeth
HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title_full HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title_fullStr HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title_full_unstemmed HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title_short HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
title_sort hla-e–restricted immune responses are crucial for the control of ebv infections and the prevention of ptld
topic Immunobiology and Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651774/
https://www.ncbi.nlm.nih.gov/pubmed/36477802
http://dx.doi.org/10.1182/blood.2022017650
work_keys_str_mv AT vietzenhannes hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld
AT furlanophilippel hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld
AT cornelissenjanj hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld
AT bohmiggeorga hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld
AT jakschpeter hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld
AT puchhammerstocklelisabeth hlaerestrictedimmuneresponsesarecrucialforthecontrolofebvinfectionsandthepreventionofptld